Ind-Swift Laboratories Limited has achieved a significant milestone in sustainability excellence by receiving the EcoVadis Silver Medal for its Global Business Unit (GBU), a 100% Export Oriented Unit located at Village Jawaharpur, Derabassi, Punjab. The company announced this achievement through a regulatory filing dated 2nd March, 2026, under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

EcoVadis Silver Medal Achievement

The Silver Medal awarded by EcoVadis places Ind-Swift Laboratories Limited among the top 15% of organizations globally assessed, reflecting strong performance across multiple sustainability parameters. EcoVadis is described as one of the world's most respected and comprehensive sustainability rating platforms, assessing companies across 200+ industries from more than 175 countries.

Comprehensive Certification Portfolio

With the EcoVadis Silver Medal, the company's Global Business Unit now holds an extensive portfolio of international certifications from reputed global certification bodies:

EcoVadis Assessment Framework

The EcoVadis evaluation methodology aligns with globally accepted frameworks and assesses organizations based on four core pillars. The assessment framework incorporates UN Global Compact Principles, International Labour Organization (ILO) Conventions, Global Reporting Initiative (GRI) Standards, and ISO 26000 Guidelines.

The four core assessment pillars include:

• Environment: Environmental sustainability and compliance measures
• Labour & Human Rights: Workplace safety and human rights standards
• Ethics: Anti-bribery and ethical governance frameworks
• Sustainable Procurement: Supply chain sustainability and oversight practices

Strategic Impact and Business Benefits

These international recognitions, awarded by internationally reputed assessors, reinforce the company's commitment to sustainability, ethics, compliance, and operational excellence. The achievements enhance the company's global credibility and eligibility for international business engagements, particularly strengthening positioning in global supply chains where ESG ratings are increasingly a prerequisite for partnerships.

The company has committed to undergo periodic surveillance and annual assessments to maintain and further strengthen these standards. Management emphasized their dedication to continuous improvement in ESG performance and sustainable value creation, with objectives of progressing toward higher sustainability benchmarks in future assessment cycles.

Ind-Swift Laboratories Limited has announced the forfeiture of ₹19,66,25,000/- following the lapse of 65,00,000 fully convertible warrants. The pharmaceutical company informed BSE and NSE on March 1, 2026, that warrant holder Saral Incorporated VCC Sub Fund 1 failed to exercise the conversion option within the prescribed timeframe.

Warrant Details and Timeline

The warrants were originally allotted on August 30, 2024, through preferential allotment with a conversion period of 18 months. The deadline for exercising the warrants was February 28, 2026, after which the unconverted warrants automatically lapsed.

Warrant Exercise Summary

Out of the total 2,60,00,000 warrants issued, the majority were successfully converted while a significant portion held by one investor lapsed.

Regulatory Compliance

The company has fulfilled its disclosure obligations under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. As per Regulation 169(3) of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, the upfront subscription amount of 25% of the issue price stands forfeited by the company.

Impact on Capital Structure

Ind-Swift Laboratories clarified that the lapse of warrants does not result in any change to the company's paid-up equity share capital. The forfeited amount will be retained by the company as per regulatory provisions. The successful exercise of 1,95,00,000 warrants indicates strong investor confidence in the majority of the allotment.